| Once-Weekly Semaglutide Use in Patients with Type 2 Diabetes: Results from the SURE Spain Multicentre, Prospective, Observational Study | | 2022 |
| Digital Interventions Supporting Self-care in People With Type 2 Diabetes Across Greater Manchester (Greater Manchester Diabetes My Way): Protocol for a Mixed Methods Evaluation | | 2022 |
| The barriers and facilitators to managing diabetes with insulin in adults with intellectual disabilities: A systemised review of the literature | | |
| Severe mental illness and quality of care for type 2 diabetes: A retrospective population-based cohort study | | 2022 |
| Diabetes UK Professional Conference 2022 highlights | | 2022 |
| Risk of all-cause mortality according to the European Society of Cardiology risk categories in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study | | 2022 |
| Potentially inappropriate prescribing for adults living with diabetes mellitus: a scoping review | International Journal of Clinical Pharmacy | |
| Strengthening the primary care workforce to deliver high-quality care for non-communicable diseases in refugee settings: lessons learnt from a UNHCR partnership | BMJ Global Health | 2022 |
| Suspected Adverse Drug Reactions of the Type 2 Antidiabetic Drug Class Dipeptidyl-Peptidase IV inhibitors (DPP4i): Can polypharmacology help explain? | | |
| Management of Diabetes and Hypertension within the Gulf Region: Updates on Treatment Practices and Therapies | Diabetes Therapy | |
| A link between frontal white matter integrity and dizziness in cerebral small vessel disease | NeuroImage: Clinical | 2022 |
| Teilnahmerate von Diabetespatient*innen an einer strukturierten Schulung und Gründe für eine Nicht-Teilnahme: eine querschnittliche Befragung von Patient*innen mit Diabetes mellitus in Thüringen | Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen | 2022 |
| Cost-Effectiveness Analysis of Initiating Type 2 Diabetes Therapy with a Sodium–Glucose Cotransporter 2 Inhibitor Versus Conventional Therapy in Japan | Diabetes Therapy | |
| A data-driven approach to identify clusters of HbA1c longitudinal trajectories and associated outcomes in type 2 diabetes mellitus: a large population-based cohort study | | |
| Effect of Metformin on Glycemic Control Regarding Carriers of the SLC22A1/OCT1 (rs628031) Polymorphism and Its Interactions with Dietary Micronutrients in Type 2 Diabetes | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | |
| Type 2 diabetes: summary of updated NICE guidance. | BMJ, The | 2022 |
| Retrospective analysis of outcomes of outpatient parenteral antimicrobial therapy (OPAT) for necrotising otitis externa. | European Journal of Clinical Microbiology and Infectious Diseases | 2022 |
| Evaluation of knowledge about gestational diabetes mellitus among postpartum women and its connection with women's sociodemographic and clinical characteristics: a quantitative cross-sectional study | Midwifery | 2022 |
| Cardiovascular outcomes of type 2 diabetic patients treated with DPP‑4 inhibitors versus sulphonylureas as add-on to metformin in clinical practice. | Scientific Reports | 2021 |
| The Cost-Effectiveness Analysis of Self-Efficacy-Focused Structured Education Program for Patients With Type 2 Diabetes Mellitus in Mainland China Setting. | Frontiers in Public Health | 2021 |
| Value of Patient-Centered Glycemic Control in Patients with Type 2 Diabetes. | Current Diabetes Reports | 2021 |
| SGLT2i agonist and GLP-1 receptor COMBination therapy in type 2 diabetes: Protocol for a KIDney endpoints real world study-[COMBi-KID Study] (Preprint) | JMIR Research Protocols | |
| All patients with type 1 diabetes in England should be offered continuous glucose monitoring, says NICE. | BMJ, The | 2022 |
| The Place and Value of Sodium-Glucose Cotransporter 2 Inhibitors in the Evolving Treatment Paradigm for Type 2 Diabetes Mellitus: A Narrative Review. | Diabetes Therapy | 2022 |
| Newer long-acting insulin prescriptions to type 2 diabetes patients: prevalence and practice variation | British Journal of General Practice | |
| Characterisation of type 2 diabetes subgroups and their association with ethnicity and clinical outcomes: a UK real-world data study using the East London Database. | British Journal of General Practice | 2022 |
| The Cost-Effectiveness of Subcutaneous Semaglutide Versus Empagliflozin in Type 2 Diabetes Uncontrolled on Metformin Alone in Denmark. | Diabetes Therapy | 2022 |
| Eliciting Requirements for a Diabetes Self-Management Application for Underserved Populations: A Multi-Stakeholder Analysis. | International Journal of Environmental Research and Public Health | 2021 |
| Extended versus immediate-release metformin. | Drug and Therapeutics Bulletin | 2022 |
| The feasibility of a self-management programme (My Life After Stroke; MLAS) for stroke survivors. | Disability and Rehabilitation | 2022 |
| Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes. | Diabetes Care | 2022 |
| Meeting the Challenge of Virtual Diabetes Care: A Consensus Viewpoint on the Positioning and Value of Oral Semaglutide in Routine Clinical Practice. | Diabetes Therapy | 2022 |
| Impact of Mental Ill Health on Medication Adherence Behaviour in Patients Diagnosed with Type 2 Diabetes | Archives of Pharmacy Practice | 2021 |
| Perceived barriers and enablers to the provision of diabetic retinopathy screening for young adults: a cross-sectional survey of healthcare professionals working in the UK National Diabetic Eye Screening Programme | BMJ Open Diabetes Research and Care | 2021 |
| Indirect effects of the COVID-19 pandemic on people with type 2 diabetes: time to urgently move into a recovery phase | BMJ Quality and Safety | 2021 |
| Compared benefits of educational programs dedicated to diabetic patients with or without community pharmacist involvement | Primary Health Care Research and Development | 2020 |
| Diabetes, Depression, and Cognitive Disorders | Endocrinology | 2020 |
| Digital Health Interventions for People With Type 2 Diabetes to Develop Self-Care Expertise, Adapt to Identity Changes, and Influence Other's Perception: Qualitative Study | Journal of Medical Internet Research | 2020 |
| Lower carbohydrate diets for adults with type 2 diabetes | British Journal of Nutrition | 2021 |
| The effectiveness of goal setting on glycaemic control for people with type 2 diabetes and prediabetes: A systematic review and meta-analysis | Journal of Advanced Nursing | 2021 |
| Avant-propos: Prise en charge du diabète de type 2 : pourquoi un consensus maghrébin ? | Medecine Des Maladies Metaboliques | 2019 |
| Diabetes, Depression, and Cognitive Disorders | Endocrinology | 2019 |
| Diabetes | Autism and Child Psychopathology Series | 2019 |
| Clinical Practice Guidelines, Evidence-Based Medicine, and Diabetes | | 2019 |
| The General Practitioner Prompt Study to Reduce Cardiovascular and Renal Complications in Patients With Type 2 Diabetes and Renal Complications: Protocol and Baseline Characteristics for a Cluster Randomized Controlled Trial | JMIR Research Protocols | 2018 |
| Diabetes, Depression, and Cognitive Disorders | Endocrinology | 2018 |
| Clinical Cardiovascular Proteomics | | 2016 |
| Assessment of the effect of the COVID-19 pandemic on UK HbA1c testing: implications for diabetes management and diagnosis | Journal of Clinical Pathology | 2021 |
| Web-Based Structured Education for Type 2 Diabetes: Interdisciplinary User-Centered Design Approach. | JMIR Human Factors | 2022 |
| Profits, Innovation and Financialization in the Insulin Industry | | 2020 |
| Engagement in e-cycling and the self-management of type 2 diabetes: a qualitative study in primary care | BJGP Open | 2019 |
| Process evaluation of integrated diabetes management at primary healthcare facilities in Pakistan: a mixed-methods study | BJGP Open | 2018 |
| Feasibility, Acceptability, and Impact of a Web-Based Structured Education Program for Type 2 Diabetes: Real-World Study | JMIR Diabetes | 2020 |
| Factors for Supporting Primary Care Physician Engagement With Patient Apps for Type 2 Diabetes Self-Management That Link to Primary Care: Interview Study | JMIR MHealth and UHealth | 2019 |
| Examining Diabetes Management Apps Recommended From a Google Search: Content Analysis | JMIR MHealth and UHealth | 2019 |
| Patients' Illness Perceptions of Type 2 Diabetes: A Scoping Review | Current Diabetes Reviews | 2019 |
| Risk factors for genital infections in people initiating SGLT2 inhibitors and their impact on discontinuation | BMJ Open Diabetes Research and Care | 2020 |
| Point-of-care testing of HbA1c, renal function and lipids in remote or disadvantaged regions | Internal Medicine Journal | 2020 |
| SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes | Diabetes Therapy | 2020 |
| Association between insulin-induced weight change and CVD mortality: Evidence from a historic cohort study of 18,814 patients in UK primary care | Diabetes/Metabolism Research and Reviews | 2018 |
| Even High-Quality CPGs Seldom Include Implementation Strategies | Frontiers in Pharmacology | 2020 |
| Assessing the Clinical Utility of Point of Care HbA1c in the Ophthalmology Outpatient Setting | Clinical Ophthalmology | 2021 |
| Severe hyperglycemia in an insulin-deficient patient with type 2 diabetes responding well to oral antidiabetic therapy | Ibnosina Journal of Medicine and Biomedical Sciences | 2021 |
| Completion of annual diabetes care processes and mortality: A cohort study using the National Diabetes Audit for England and Wales | Diabetes, Obesity and Metabolism | 2021 |
| Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from the SURE UK Multicentre, Prospective, Observational Study | Diabetes Therapy | 2021 |
| Evaluation of a Community Health Worker Social Prescribing Program Among UK Patients With Type 2 Diabetes | JAMA Network Open | 2021 |
| An analysis of frailty and multimorbidity in 20,566 UK Biobank participants with type 2 diabetes | Communications Medicine | 2021 |
| Thiazolidinediones and Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Nonalcoholic Fatty Liver Disease: A Cohort Study | Hepatology | 2021 |
| Exploring dietitians' practice and views of giving advice on dietary patterns to patients with type 2 diabetes mellitus: A qualitative study | Journal of Human Nutrition and Dietetics | 2021 |
| Low Carbohydrate Dietary Approaches for People With Type 2 Diabetes-A Narrative Review | Frontiers in Nutrition | 2021 |
| Participation in structured diabetes self-management education programs and its associations with self-management behaviour - a nationwide population-based study | Patient Education and Counseling | 2021 |
| Historical HbA Values May Explain the Type 2 Diabetes Legacy Effect: UKPDS 88 | Diabetes Care | 2021 |
| Educational programmes for frail older people, their families, carers and healthcare professionals : A systematic review | Wiener Klinische Wochenschrift | 2021 |
| Glucagon-Like Peptide 1 Receptor Agonist Usage in Type 2 Diabetes in Primary Care for the UK and Beyond: A Narrative Review | Diabetes Therapy | 2021 |
| Knowledge, Attitude, and Practice of Metformin Extended-Release Tablets Among Clinicians in China: A Cross-Sectional Survey | Frontiers in Pharmacology | 2021 |
| Exploring support needs of people living with diabetes during the coronavirus COVID-19 pandemic: insights from a UK survey | BMJ Open Diabetes Research and Care | 2021 |
| Cohort profile: National Diabetes Audit for England and Wales | Diabetic Medicine | 2021 |
| Prescribing sodium-glucose co-transporter-2 inhibitors for type 2 diabetes in primary care: influence of renal function and heart failure diagnosis | Cardiovascular Diabetology | 2021 |
| Technology in the management of type 2 diabetes: Present status and future prospects | Diabetes, Obesity and Metabolism | 2021 |
| Initiation of four basal insulins and subsequent treatment modification in people treated for type 2 diabetes in the United Kingdom: Changes over the period 2003-2018 | Diabetic Medicine | 2021 |
| Antihypertensive medication needs and blood pressure control with weight loss in the Diabetes Remission Clinical Trial (DiRECT) | Diabetologia | 2021 |
| SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline | BMJ, The | 2021 |
| Associations between attainment of incentivised primary care indicators and incident diabetic retinopathy in England: a population-based historical cohort study | BMC Medicine | 2021 |
| Effect of Group Patient Education on Glycemic Control Among People Living with Type 2 Diabetes in Vietnam: A Randomized Controlled Single-Center Trial | Diabetes Therapy | 2021 |
| Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabetes Mellitus: Data from a Real-World Study in Spain | Diabetes Therapy | 2021 |
| Timely testing: who needs to do what differently to improve adherence to guideline-recommended glycaemic monitoring? | BMJ Quality and Safety | 2021 |
| One Hundred Years of Insulin: Value Beyond Price in Type 2 Diabetes Mellitus | Diabetes Therapy | 2021 |
| Global prevalence and types of complementary and alternative medicines use amongst adults with diabetes: systematic review and meta-analysis | European Journal of Clinical Pharmacology | 2021 |
| Diabetes and Cardiovascular Risk in Renal Transplant Patients | International Journal of Molecular Sciences | 2021 |
| Contextualizing Evidence for Action on Diabetes in Low-Resource Settings-Project CEAD Part-II, Strengthening the Health System: A Mixed-Methods Study Protocol | International Journal of Environmental Research and Public Health | 2021 |
| Impact of the UK COVID-19 pandemic on HbA1c testing and its implications for diabetes diagnosis and management | International Journal of Clinical Practice | 2021 |
| The cost-effectiveness of dapagliflozin in treating high-risk patients with type 2 diabetes mellitus: An economic evaluation using data from the DECLARE-TIMI 58 trial | Diabetes, Obesity and Metabolism | 2021 |
| The rapid effects of sleeve gastrectomy on glucose homeostasis and resolution of diabetes mellitus | Endocrinology, Diabetes and Metabolism | 2021 |
| Treatment intensification in type 2 diabetes management after the failure of two oral hypoglycemic agents: A non-interventional comparative study | International Journal of Clinical Practice | 2021 |
| Efficacy and safety of a sodium-glucose co-transporter-2 inhibitor versus placebo as an add-on therapy for people with type 2 diabetes inadequately treated with metformin and a dipeptidyl peptidase-4 inhibitor: a systematic review and meta-analysis of randomised controlled trials | Diabetic Medicine | 2021 |
| The Place of Sulfonylureas in Guidelines: Why Are There Differences? | Diabetes Therapy | 2020 |
| An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines | Diabetes, Obesity and Metabolism | 2020 |
| Dulaglutide: A Review in Type 2 Diabetes | Drugs | 2020 |
| Impact of Being Eligible for Type 2 Diabetes Treatment on All-Cause Mortality and Cardiovascular Events: Regression Discontinuity Design Study | Clinical Epidemiology | 2020 |
| Prescribing Paradigm Shift? Applying the 2019 European Society of Cardiology-Led Guidelines on Diabetes, Prediabetes, and Cardiovascular Disease to Assess Eligibility for Sodium-Glucose Cotransporter 2 Inhibitors or Glucagon-Like Peptide 1 Receptor Agonists as First-Line Monotherapy (or Add-on to Metformin Monotherapy) in Type 2 Diabetes in Scotland | Diabetes Care | 2020 |
